When a House committee approved an amendment to a large-scale agriculture bill last week that would effectively ban most consumable hemp products, it was met with an atypically mixed response from the cannabis industry. Even within trade associations that supported the amendment to the 2024 Farm Bill, such as the U.S. Cannabis Council (USCC), there’s been internal splintering.
Multi-state cannabis operators like Cresco Labs and Curaleaf—both members of USCC that typically find themselves aligned on federal reform issues—are at odds over the hemp amendment, for example.
Everyone generally seems to agree that marijuana and hemp should be regulated under a federal framework, but there’s disagreement over the measure adopted by the House Agriculture Committee, which calls for a ban on intoxicating hemp-derived cannabinoid products such as delta-8 THC and CBD products containing any quantifiable amount of THC.
Supporters of the amendment have described it as a fix to a “loophole” in the 2018 Farm Bill that federally legalized hemp and its constituents. Others have recognized the need to adopt regulations to reign in the cannabinoid market but say re-prohibiting cannabinoids is not the solution.
“Our position is, it’s the same plant and should be regulated the same way, period,” Jason
Read full article on Marijuana Moment
